We have previously shown that MTH1 is elevated in HRASV12-transformed breast cancer cells relative to their non-transformed counterparts and that MTH1 overexpression enables normal cells to overcome oncogene-induced senescence (OIS), the first barrier to oncogenic transformation [9]. The gene discussed is NUDT1; the disease is breast cancer.